Anticancer Bioscience Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
50
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Anticancer Bioscience General Information
Description
Developer of precision therapeutics designed for synthetic lethal cancer therapies. The company utilises artificial intelligence drug discovery, mechanism-informed phenotypic screening, a synthetic lethal approach, small-molecule drug discovery, natural product drug discovery, and lead optimisation, providing the healthcare sector with biomarker-driven cancer therapies.
Contact Information
Website
www.anticancerbio.comCorporate Office
- Chengdu Tianfu International Bio-city
- Chengdu, Sichuan 610219
- China
Corporate Office
- Chengdu Tianfu International Bio-city
- Chengdu, Sichuan 610219
- China
Anticancer Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 31-Dec-2025 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 26-Sep-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 08-Feb-2021 | $9.7M | $20.4M | Completed | Generating Revenue | |
| 1. Seed Round | $10.6M | $10.6M | Completed | Startup |
Anticancer Bioscience Patents
Anticancer Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260175276-A1 | Sheet metal drawing machine | Pending | 20-Dec-2024 | ||
| EP-4763372-A1 | Sheet metal stretch forming machine | Pending | 20-Dec-2024 | ||
| FR-3170355-A1 | Sheet metal stretch forming machine | Pending | 20-Dec-2024 | ||
| FR-3060425-A1 | Longitudinal stretch shape forming machine | Active | 19-Dec-2016 | ||
| FR-3060425-B1 | Longitudinal stretch shape forming machine | Inactive | 19-Dec-2016 | B21D25/00 |
Anticancer Bioscience Signals
Anticancer Bioscience Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CY Capital | Venture Capital | Minority | ||
| Dunhong Capital Management | PE/Buyout | Minority |
Anticancer Bioscience FAQs
-
When was Anticancer Bioscience founded?
Anticancer Bioscience was founded in 2016.
-
Where is Anticancer Bioscience headquartered?
Anticancer Bioscience is headquartered in Chengdu, China.
-
What is the size of Anticancer Bioscience?
Anticancer Bioscience has 50 total employees.
-
What industry is Anticancer Bioscience in?
Anticancer Bioscience’s primary industry is Drug Discovery.
-
Is Anticancer Bioscience a private or public company?
Anticancer Bioscience is a Private company.
-
What is Anticancer Bioscience’s current revenue?
The current revenue for Anticancer Bioscience is .
-
How much funding has Anticancer Bioscience raised over time?
Anticancer Bioscience has raised $31M.
-
Who are Anticancer Bioscience’s investors?
CY Capital and Dunhong Capital Management have invested in Anticancer Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process